Xingliang Dai
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 15
- 3D Printing in Biomedical Research 13
- Genetics top 5%
- Glioma Diagnosis and Treatment 15
- Biomaterials top 5%
- Automotive Engineering top 5%
- Oncology top 5%
- Cancer Cells and Metastasis 18
-
- Cancer Research and Treatments 13
-
- Cancer, Hypoxia, and Metabolism 8
-
- Advanced Nanomaterials in Catalysis 7
-
- Immune cells in cancer 6
- Journals
- SHILAP Revista de lepidopterología (3 papers)Biomaterials (1 paper)Chemical Communications (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xingliang Dai
79 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 124
- Biomedical Engineering 1.2k
- Genetics 240
- Biomaterials 260
- Automotive Engineering 235
- Oncology 474
Countries citing papers authored by Xingliang Dai
This map shows the geographic impact of Xingliang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingliang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingliang Dai more than expected).
Fields of papers citing papers by Xingliang Dai
This network shows the impact of papers produced by Xingliang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingliang Dai. The network helps show where Xingliang Dai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xingliang Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 8 | |
| 4 | 2023 | 12 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 14 | |
| 7 | 2023 | 62 | |
| 8 | 2023 | 12 | |
| 9 | 2022 | 80 | |
| 10 | 2022 | 68 | |
| 11 | 2022 | 46 | |
| 12 | 2022 | 37 | |
| 13 | 2022 | 79 | |
| 14 | 2022 | 28 | |
| 15 | 2022 | 77 | |
| 16 | 2022 | 3 | |
| 17 | 2018 | 49 | |
| 18 | 2018 | 89 | |
| 19 | 2018 | 40 | |
| 20 | 2017 | 140 |
About Xingliang Dai
Xingliang Dai is a scholar working on Genetics, Biotechnology and Cancer Research, having authored 80 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (18 papers), Glioma Diagnosis and Treatment (15 papers), Nanoplatforms for cancer theranostics (15 papers), 3D Printing in Biomedical Research (13 papers), Cancer Research and Treatments (13 papers), Cancer, Hypoxia, and Metabolism (8 papers), Advanced Nanomaterials in Catalysis (7 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Biomedical Engineering (1.2k citations), Genetics (240 citations) and Biomaterials (260 citations). Xingliang Dai has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qing Lan, Tao Xu, Xianwen Wang, Haisheng Qian, Cheng Ma, Xinzhi Zhang, Xinda Li, Xuanzhi Wang, Hongwei Cheng and Hua Wang. Their work appears in journals such as SHILAP Revista de lepidopterología, Biomaterials and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.